Catalyst Pharmaceuticals, Inc.
CPRX
|
News
|
$15.12
2.65%
2.58%
940K
|
Health Technology
(0.0% 1d) (-5.9% 1m) (-7.5% 1y) (0.0% 2d) (0.6% 3d) (-2.9% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 1,784,327,711
http://www.catalystpharma.com
Sec Filling | Patents | 76 employees
(US) Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
antibody neurological
Drugs
Firdapse (amifampridine phosphate)add to watch list Paper trade email alert is off
Press-releases
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
Published: 2024-04-25 (Crawled : 05:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
| Email alert
Add to watchlist
report update publication results
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 0.13%
H: 0.46%
C: -1.18%
first report pharmaceuticals financial results
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 0.12%
H: 1.29%
C: -2.15%
day pharmaceuticals
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 0.95%
H: 4.72%
C: 2.33%
symposium pharmaceuticals
Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China’s NMPA
Published: 2024-03-27 (Crawled : 06:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 0.95%
H: 4.72%
C: 2.33%
granted review duchenne
Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
Published: 2024-03-14 (Crawled : 06:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: -4.88%
agamree pharmaceuticals
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 1.46%
H: 3.13%
C: 1.12%
agamree treatment pharmaceuticals duchenne
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 0.06%
H: 0.57%
C: -2.57%
conference pharmaceuticals global
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-02-28 (Crawled : 23:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 11.88%
H: 1.29%
C: -1.6%
business year update pharmaceuticals financial results
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 940K
|
Health Technology
|
| O: 0.21%
H: 1.34%
C: 0.99%
conference life pharmaceuticals registry agamree duchenne study
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10